NKX2-1 gene is targeted by H19 lncRNA and is found to be overexpressed in benign nodular goiter tissues

Seyed-Morteza Javadirad1

  • 1University of Isfahan, Faculty of Biological Science and Technology, Department of Cell and Molecular Biology and Microbiology, Isfahan, Iran.

Abstract

Insights

The long non-coding RNA H19 is overexpressed in nodular goiter. Researchers identified NKX2-1 as a target of H19, suggesting a role in goiter development.

Area of Science:

  • Molecular Biology
  • Genetics
  • Endocrinology

Background:

  • Nodular goiter may increase thyroid cancer risk, with unclear genetic factors.
  • H19 long non-coding RNA (lncRNA) is overexpressed in goiter tissue, but its target is unknown.

Purpose of the Study:

  • To identify a novel target for H19 lncRNA in the context of nodular goiter development.
  • Investigate the interaction between H19 lncRNA and NKX2-1 mRNA.

Main Methods:

  • Interaction energy calculations to analyze H19-NKX2-1 binding.
  • RNA sequencing to assess gene expression tissue specificity.
  • RT-qPCR to quantify NKX2-1 expression in 18 goiter and 18 normal thyroid tissues.

Main Results:

  • H19 binds to NKX2-1 mRNA with high affinity, overlapping with has-miR-1827 binding site.
  • NKX2-1 is co-expressed with H19 exclusively in normal thyroid tissue.
  • NKX2-1 is significantly overexpressed in nodular goiter tissues compared to normal tissues (p=0.038).

Conclusions:

  • NKX2-1 is identified as a putative target of H19 lncRNA.
  • H19 lncRNA overexpression in nodular goiter is linked to NKX2-1 dysregulation.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K